Burcon NutraScience Corporation

As of June 30, 2026, Burcon NutraScience Corporation carries a market capitalization of 24.50M, placing it among publicly traded companies globally. Its enterprise value stands at 49.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Burcon NutraScience Corporation's next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Burcon NutraScience Corporation has 12.69M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 7.66, and the price-to-book ratio stands at -2.71.

These figures are as of June 30, 2026. The EV/Sales ratio of 15.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 49.29M versus a market cap of 24.50M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Burcon NutraScience Corporation maintains a current ratio of 0.21, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -283.42, indicating conservative leverage, while an interest coverage ratio of -2.84 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -57.98, reflecting losses generated across the asset base. The company generates approximately 220,599.24 in revenue per employee across its workforce of 14.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.89 indicates how many times Burcon NutraScience Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Burcon NutraScience Corporation recorded an income tax benefit of -207,147.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -15.14M and -14.54M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 2, 2026, Burcon NutraScience Corporation's stock has declined approximately 52.96% over the past 52 weeks. The 50-day moving average sits at 2.08, while the 200-day moving average is 2.86.

Over the twelve months ended June 30, 2026, Burcon NutraScience Corporation generated 3.20M in revenue and converted that into -14.54M in net income, yielding earnings per share of -1.15. EBITDA reached -10.72M, while operating income came in at -12.05M.

As of June 30, 2026, Burcon NutraScience Corporation holds 866,464.00 in cash and equivalents against 25.66M in total debt, resulting in a net debt position of 8.70M. Total book value stands at -9.05M, with working capital of -11.23M providing operational flexibility.

Burcon NutraScience Corporation produced -8.86M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -865,770.00 in capital expenditures, free cash flow totaled -9.73M - equivalent to -0.77 per share.

Over the twelve months ended June 30, 2026, Burcon NutraScience Corporation posted a gross margin of -254.09, reflecting its pricing power and cost economics. The operating margin of -376.60 and net profit margin of -454.70 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -39.72: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -25.45, meaning Burcon NutraScience Corporation raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Burcon NutraScience Corporation's most recent stock split took place on June 17, 2025 with a 20:1 split ratio.

As of June 30, 2026, Burcon NutraScience Corporation has an Altman Z-Score of -15.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.